113 related articles for article (PubMed ID: 3257685)
21. Bioactive interleukin-8 is expressed in wounds and enhances wound healing.
Rennekampff HO; Hansbrough JF; Kiessig V; Doré C; Sticherling M; Schröder JM
J Surg Res; 2000 Sep; 93(1):41-54. PubMed ID: 10945942
[TBL] [Abstract][Full Text] [Related]
22. Wound fluid of rats fed protein-free diets delays wound healing through the suppression of the IGF-1/ERK(1/2) signaling pathway.
Yamane T; Shimura M; Konno R; Iwatsuki K; Oishi Y
Mol Cell Biochem; 2019 Feb; 452(1-2):177-185. PubMed ID: 30143989
[TBL] [Abstract][Full Text] [Related]
23. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
Chiba K; Nishimura T; Hashimoto Y
J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
[TBL] [Abstract][Full Text] [Related]
24. Synergistic interactions of IL-1 and IL-6 in T cell activation. Mitogen but not antigen receptor-induced proliferation of a cloned T helper cell line is enhanced by exogenous IL-6.
Mizutani H; May LT; Sehgal PB; Kupper TS
J Immunol; 1989 Aug; 143(3):896-901. PubMed ID: 2526177
[TBL] [Abstract][Full Text] [Related]
25. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats.
Rott O; Cash E; Fleischer B
Eur J Immunol; 1993 Aug; 23(8):1745-51. PubMed ID: 8393796
[TBL] [Abstract][Full Text] [Related]
26. Production of a fibroblast-stimulating factor by Schistosoma mansoni antigen-reactive T cell clones.
Lammie PJ; Michael AI; Linette GP; Phillips SM
J Immunol; 1986 Feb; 136(3):1100-6. PubMed ID: 3510253
[TBL] [Abstract][Full Text] [Related]
27. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression.
De AK; Kodys KM; Pellegrini J; Yeh B; Furse RK; Bankey P; Miller-Graziano CL
Clin Immunol; 2000 Jul; 96(1):52-66. PubMed ID: 10873428
[TBL] [Abstract][Full Text] [Related]
28. Wound fluids: a reflection of the state of healing.
Staiano-Coico L; Higgins PJ; Schwartz SB; Zimm AJ; Goncalves J
Ostomy Wound Manage; 2000 Jan; 46(1A Suppl):85S-93S; quiz 94S-95S. PubMed ID: 10732643
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor.
Pierce GF; Mustoe TA; Lingelbach J; Masakowski VR; Gramates P; Deuel TF
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2229-33. PubMed ID: 2928327
[TBL] [Abstract][Full Text] [Related]
30. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
31. Lymphokine control of type 2 antigen response. IL-10 inhibits IL-5- but not IL-2-induced Ig secretion by T cell-independent antigens.
Peçanha LM; Snapper CM; Lees A; Mond JJ
J Immunol; 1992 Jun; 148(11):3427-32. PubMed ID: 1534095
[TBL] [Abstract][Full Text] [Related]
32. Retrovirus infection alters growth factor responses of T lymphocytes.
Lichtman AH; Williams ME; Ohara J; Paul WE; Faller DV; Abbas AK
J Immunol; 1987 May; 138(10):3276-83. PubMed ID: 3033071
[TBL] [Abstract][Full Text] [Related]
33. Permissive environment in postnatal wounds induced by adenoviral-mediated overexpression of the anti-inflammatory cytokine interleukin-10 prevents scar formation.
Gordon A; Kozin ED; Keswani SG; Vaikunth SS; Katz AB; Zoltick PW; Favata M; Radu AP; Soslowsky LJ; Herlyn M; Crombleholme TM
Wound Repair Regen; 2008; 16(1):70-9. PubMed ID: 18086289
[TBL] [Abstract][Full Text] [Related]
34. L-arginine: a unique amino acid for improving depressed wound immune function following hemorrhage.
Angele MK; Nitsch SM; Hatz RA; Angele P; Hernandez-Richter T; Wichmann MW; Chaudry IH; Schildberg FW
Eur Surg Res; 2002; 34(1-2):53-60. PubMed ID: 11867902
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid.
Akinci B; Terzi C; Sevindik G; Yuksel F; Tunc UA; Tunali S; Yesil S
J Diabetes Complications; 2014; 28(6):844-9. PubMed ID: 25179235
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide in the healing wound: a time-course study.
Lee RH; Efron D; Tantry U; Barbul A
J Surg Res; 2001 Nov; 101(1):104-8. PubMed ID: 11676563
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells.
Koide SL; Inaba K; Steinman RM
J Exp Med; 1987 Feb; 165(2):515-30. PubMed ID: 2950198
[TBL] [Abstract][Full Text] [Related]
38. Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. II. Establishment of a T cell hybrid clone constitutively producing killer-helper factor(s) (KHF) and functional analysis of released KHF.
Kikuchi Y; Kato R; Sano Y; Takahashi H; Kanatani T; Takatsu K
J Immunol; 1986 May; 136(10):3553-60. PubMed ID: 2939132
[TBL] [Abstract][Full Text] [Related]
39. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.
Suzuki R; Suzuki S; Igarashi M; Kumagai K
J Immunol; 1986 Sep; 137(5):1564-72. PubMed ID: 2427574
[TBL] [Abstract][Full Text] [Related]
40. [The modern approach to wound treatment].
Komarcević A
Med Pregl; 2000; 53(7-8):363-8. PubMed ID: 11214479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
